Oxaliplatin plus irinotecan seems highly promising as a first-line treatment option

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1327, 2002-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Irinotecan plus docetaxel a first-line option for NSCLC

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Lithium is still a first-line option in the treatment of patients with bipolar disorder

Drugs & Therapy Perspectives, Vol. 26, Iss. 3, 2010-03 ,pp. : 9-14

Adis International

Access to resources Recommend Favorite

Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer

By Méndez M. Alfonso P. Pujol E. González E. Castañon C. Cerezuela P. López-Mateos Y. Cruz J.

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 243-251

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine, oxaliplatin plus erlotinib is promising for the treatment of metastatic colorectal cancer

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Oral fludarabine: a first-line option for CLL

Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite